ArticlePediatric pulmonology2026
Non-Linear Dysanaptic Lung Growth in Patients With Post-Infectious Bronchiolitis Obliterans.
Article in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionFew studies have assessed longitudinal pulmonary function outcomes in post-infectious bronchiolitis obliterans (PIBO). This study analyzes pulmonary function changes from patients with PIBO at a single center with respect to time and inciting respiratory pathogen.
methodsPatients with PIBO were identified via retrospective observation using the Research Derivative at Vanderbilt University Medical Center. Serial spirometry was analyzed by generalized mixed-effects models. An exploratory analysis was performed to test interactions with pathogen, age at sentinel infection, and systemic corticosteroid exposure.
resultsFifteen patients were diagnosed with PIBO from 1998 to 2023. Twelve (80%) were male. Median age of infection was 3.0 years (IQR: 1.3-6.5 years). Commonly identified pathogens were adenovirus (n = 8/15) and Mycoplasma pneumoniae (n = 4/15). Patients with M. pneumoniae were older at infection (p = 0.02). Eleven (73%) patients performed a median of 14 pulmonary function tests per patient (IQR: 6.5-23). Median z-scores at initial spirometry were forced expiratory volume in 1 second (FEV1) -3.83, forced vital capacity (FVC) -2.92, and FEV1/FVC ratio -2.61. FEV1, FVC, and FEV1/FVC z-scores changed by 0.008, 0.185, and -0.143/year, respectively (p = 0.69, 0.003, 0.004). Four of 9 (44%) patients tested were bronchodilator responsive. The rate of annual FVC z-scores improved more in adenovirus-infected patients than in those with other pathogens (p < 0.001).
conclusionPatients with PIBO demonstrate non-linear dysanaptic lung growth with stagnant FEV1 growth with respect to time. Subjects infected with adenovirus demonstrated lower FVC initially but accelerated FVC growth than those infected with other pathogens. Future research is needed on how severe respiratory infections contribute to non-linear dysanaptic lung growth in susceptible children.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.